Michels, S., Massuti, B., Vasyliv, I., Stratmann, J., Frank, J., Adams, A., . . . Wolf, J. (2024). Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancerdfinal results of the EUCROSS trial.
Citación estilo ChicagoMichels, S., et al. Overall Survival and Central Nervous System Activity of Crizotinib in ROS1-rearranged Lung Cancerdfinal Results of the EUCROSS Trial. 2024.
Cita MLAMichels, S., et al. Overall Survival and Central Nervous System Activity of Crizotinib in ROS1-rearranged Lung Cancerdfinal Results of the EUCROSS Trial. 2024.
Precaución: Estas citas no son 100% exactas.